More high-profile brands desert the Baselworld fair
Rolex, Patek Philippe and Chanel will not exhibit at the Baselworld watch and jewellery trade show in 2021. The announcement marks another blow to the event, which has already seen high-profile exits, including by the Swatch Group.
The luxury timepiece companies, along with Chopard and Tudor said on Tuesday they would launch a new trade show in Geneva with the Fondation de la Haute Horlogerie industry group, in April 2021.
Rolex said it was unhappy with changes at Baselworld and recent decisions made by organiser MCH Group, which postponed the 2020 edition of Baselworld planned for April 30 – May 5 due to the coronavirus epidemic.
MCH carried forward 85% of the fees for exhibitors to next year, while keeping 15% to offset out-of-pocket costs, among options it offered exhibitors as it sought to manage the financial impact.
“We have taken part in Baselworld since 1939,” Rolex said in a joint statement with the other watch makers. “Unfortunately, given the way the event has evolved and the recent decisions made by MCH Group…we have decided to withdraw.”
Geneva-based Patek Philippe cited a breakdown in relations with Baselworld organisers, saying the company “is not in line with Baselworld’s vision anymore” and that “trust is no longer present”.
MCH Group, which last month predicted sales losses of up to 170 million francs ($177 million) for 2020 as the epidemic wreaks havoc on events, declined to comment.
Swatch Group, the maker of Omega watches, left Baselworld in 2019, citing issues including costs.
Popular Stories
More
Culture
Wealth is not all: how gentrification in Zurich has led to housing shortage
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
EU Commission president says Swiss-EU deal is ‘historic’ agreement
This content was published on
At a joint media conference with Swiss President Viola Amherd in Bern, European Commission President Ursula von der Leyen spoke of a "day of joy".
Switzerland and EU reach deal on future bilateral relations
This content was published on
Switzerland and the European Union have announced a political agreement to update their trading relationship after almost a decade of difficult talks.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Start-ups out to conquer the watchmaking world
This content was published on
With several traditional watchmakers not in attendance, Baselworld has this year launched a platform to showcase industry start-ups.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.